6FDA.Final Report on Pharmaceutical cGMPs for the 21st Century-A Risk-Based Approach[EB/OL].(2004-09)[2014-03-20].http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/Manufacturing/QuestionsandAnswersonCurrentGoodManufacturin-gPracticescGMPforDrugs/UCM176374.pdf.
7FDA,ICH.Guidance for Industry: Q8 Pharmaceutical Development[EB/OL].(2006-05)[2014-03-20].http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm128029.pdf.
8FDA,ICH.Guidance for Industry: Q9 Quality Risk Management[EB/OL].(2006-06)[2014-03-20].http://www.fda.gov/downloads/Drugs/Guidances/ucm073511.pdf.
9FDA,ICH.Guidance for Industry: Q10 Pharmaceutical Quality System[EB/OL].(2009-04)[2014-03-20].http://www.fda.gov/downloads/Drugs/Guidances/ucm073517.pdf.
10FDA.Guidance for Industry: Process Validation-General Principles and Practices[EB/OL].(2011-01)[2014-03-20].http://www.fda.gov/downloads/Drugs/Guidances/UCM070336.pdf.